Skip Navigation LinksHome > May 1985 - Volume 10 - Issue 4 > Baclofen for the Treatment of Acute Low-Back Syndrome: A Dou...
Spine:
Original Article: PDF Only

Baclofen for the Treatment of Acute Low-Back Syndrome: A Double-Blind Comparison with Placebo.

DAPAS, FRANCES MD; HARTMAN, STANFORD F. MD; MARTINEZ, LUCAS MD; NORTHRUP, B E MD; NUSSDORF, R THEODORE MD; SILBERMAN, HAROLD M. MD; GROSS, HOWARD MD

Collapse Box

Abstract

The efficacy and safety of baclofen (30-80 mg daily) for the treatment of acute low-back syndrome were evaluated in a 14-day, double-blind, randomized study of 200 patients (100 baclofen, 100 placebo). Patients with initially severe or extremely severe symptoms (as opposed to moderate symptoms) benefitted most from treatment with baclofen. The incidence of adverse effects was significantly higher in the baclofen group; however, most were mild to moderate and disappeared in all but two patients who required a reduction in dosage, without reduced drug efficacy. Baclofen was shown to be effective, safe, and well-tolerated for the treatment of patients with acute low-back syndrome.

(C) Lippincott-Raven Publishers.

Follow Us!

  

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.